RNAC: Bathi resik saben saham (EPS TTM) Cartesian Therapeutics Inc

Logo perusahaan publik Selecta Biosciences (RNAC)

Cartesian Therapeutics (RNAC) develops RNA-based drugs to combat cancer and autoimmune pathologies, diversifying risks across various disease types. The company's net income per share over 12 months settled at -4.99, providing a basis to assess the efficiency of its capital management. Despite high production costs and fierce scientific competition, the brand maintains strong authority and investor confidence.

RNAC (Cartesian Therapeutics) riwayat Bathi resik saben siji saham sajrone rolas wulan pungkasan saka 21.02.2024 nganti 10.11.2026

Selecta Biosciences - rincian analitis lan metrik utama (RNAC)

- rega saham lan prakiraan rega para ahli:
Kutipan saham Cartesian Therapeutics|RNAC - Konsensus nilai wajar
- informasi kapitalisasi pasar:
Kapitalisasi pasar Cartesian Therapeutics, Inc.|RNAC - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- rincian valuasi buku bisnis:
Nilai Buku saben Saham Cartesian Therapeutics|RNAC - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku selectabio.com|RNAC - Aset Agregat Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Cartesian Therapeutics|RNAC - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Cartesian Therapeutics Inc|RNAC - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Cartesian Therapeutics, Inc.|RNAC - Tanggungan jangka dawa|Utang jangka cendhak perusahaan Cartesian Therapeutics|Likuiditas cepet selectabio.com
- indikator pendapatan resik lan kelipatan nilai:
RNAC - Bathi perusahaan|Proyeksi bathi mangsa ngarep Cartesian Therapeutics|RNAC - Kapitalisasi marang bathi|Prakiraan rega marang bathi Cartesian Therapeutics, Inc.|RNAC - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cartesian Therapeutics, Inc.|RNAC - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Cartesian Therapeutics|RNAC - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan selectabio.com|RNAC - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cartesian Therapeutics
Analisis umum perusahaan:Cartesian Therapeutics (RNAC)
Produk seri Selecta Biosciences Inc.

Annual net income per share reflects the actual earnings of a single security holder, excluding temporary market fluctuations. By analyzing the TTM net income per share, an investor assesses the capital allocation efficiency of Cartesian Therapeutics (RNAC), where financial stability is bolstered by the implementation of sustainable ESG standards and strict adherence to biosafety protocols in the development of innovative gene therapies.

Analisis perusahaan pesaing

LEGN: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku SANA (sana.com)|AUTL: Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan Allogene Therapeutics, Inc.|CLLS (Cellectis SA) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Caribou Biosciences, Inc CRBU|Bathi saben saham sajrone rolas wulan pungkasan Instil Bio, Inc. (TIL)|Bathi saben saham sajrone rolas wulan pungkasan GNTA (genenta.com)|Bathi saben saham sajrone rolas wulan pungkasan Century Therapeutics, Inc. IPSC|Jasper Therapeutics Inc - Bathi saben saham sajrone rolas wulan pungkasan|SNTI: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku ADAP (Adaptimmune)|CERO: Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajroning taun lumaku Alaunos Therapeutics, Inc. TCRT|ACHL (Achilles Therapeutics PLC) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan CARGO Therapeutics Inc. CRGX|Bathi saben saham sajrone rolas wulan pungkasan Poseida (PSTX)|2seventy bio, Inc - Bathi saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) GRCL (Gracell Biotechnologies)